Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III trial of DL-3-n-butylphthalide injection vs DL-3-n-butylphthalide sodium chloride injection in acute ischemic stroke
CTR20251559Phase 3Active
- Sponsor
- Sepure
- Start
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of butylphthalide in ischemic stroke, sponsored by Sepure. Started Apr 2025; status: active.
02
Drugs
butylphthalide
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on CTR20251559.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20251559.